Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03480984 · ClinicalTrials.gov registry record · NA

Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery

A NA study of Thoracic Diseases, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03480984 is a NA study of Thoracic Diseases that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 1,074-participant average among 7 other Thoracic Diseases trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03480984, a NA study of Thoracic Diseases, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient controlled pain medication as well as the same dose of pre-programmed pain medication. The only difference is the rate of administration: continuous vs. hourly intervals.

Conditions Studied

Interventions

  • OTHER Programmed Intermittent Bolus
  • OTHER Continuous Infusion

Study Locations (1)

Florida

  • Mayo Clinic - Jacksonville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-02-05
Est. Completion 2020-01-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03480984

The ClinicalTrials.gov registry entry for NCT03480984 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,074-participant average among 7 other Thoracic Diseases trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thoracic Diseases appearing as the primary indexed condition, and to 2 interventions - of which Programmed Intermittent Bolus is the first listed.

NCT03480984 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03480984 about?

NCT03480984 is a clinical study titled "Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery". The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient ...

What is the current status of trial NCT03480984?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-02-05. Estimated completion is 2020-01-31.

What conditions does trial NCT03480984 study?

This clinical trial studies the following conditions: Thoracic Diseases.

What interventions are being tested in trial NCT03480984?

The interventions under investigation include: Programmed Intermittent Bolus (OTHER), Continuous Infusion (OTHER).

Who is sponsoring clinical trial NCT03480984?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03480984 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.